Processing your request


please wait...

Case Page

 

Case Status:    DISMISSED    
On or around 11/25/2019 (Notice of voluntarily dismissal)

Filing Date: October 10, 2019

According to the Complaint, Plaintiff asserts this action to remedy the alleged false and misleading disclosures made by Organovo and its Board of Directors in the Company’s proxy statement related to its 2019 annual meeting of stockholders.

This case was voluntarily dismissed on November 25, 2019.

COMPANY INFORMATION:

Sector: Healthcare
Industry: Biotechnology & Drugs
Headquarters: United States

SECURITIES INFORMATION:

Ticker Symbol: ONVO
Company Market: NASDAQ
Market Status: Public (Listed)

About the Company & Securities Data


"Company" information provides the industry and sector classification and headquarters state for the primary company-defendant in the litigation. In general, "Securities" information provides the ticker symbol, market, and market status for the underlying securities at issue in the litigation.

In most cases, the primary company-defendant actually issued the securities that are the subject of the litigation, and the securities information and company information relate to the same entity. In a small subset of cases, however, the primary company-defendant is not the issuer (for example, cases against third party brokers/dealers), and the securities information and company information do not relate to the same entity.
COURT: D. Delaware
DOCKET #: 19-CV-01922
JUDGE: Hon. Maryellen Noreika
DATE FILED: 10/10/2019
CLASS PERIOD START: 07/26/2019
CLASS PERIOD END: 10/10/2019
PLAINTIFF FIRMS NAMED IN COMPLAINT:
  1. Farnan LLP
  2. Levi & Korsinsky LLP (New York)
No Document Title Filing Date
—Reference Complaint Complaint Related Data is not available
—Related District Court Filings Data is not available